Yes, Pat, there is the exclusivity clause with Gerresheimer, but that doesn't necessarily mean an agreement will take that long to conclude. License and royalty fees with global pharma will underpin everything moving forward. Once this is locked in, other agreements will fall into place. The amounts involved will raise eyebrows leaving all the sceptics scrambling to get on board.
production timeline, page-5
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UNI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.99 |
Change
-0.060(1.19%) |
Mkt cap ! $382.8M | |||
| Open | High | Low | Value | Volume |
| $5.10 | $5.10 | $4.79 | $450.0K | 91.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 21643 | $4.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| UNI (ASX) Chart |